Historical record - last NADAC publication: 12/23/2022
Product Information
ENVARSUS XR 1 MG TABLET is a brand product labeled by Veloxis Pharmaceuticals, Inc, priced at $6.1904 per EA under NDC 68992301003. Its NADAC has been published 78 times since Oct 20, 2021.
The High Outlier badge above means this manufacturer's average price in the Tacrolimus market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
1 mg/1
Manufacturer
Veloxis Pharmaceuticals, IncNDC
68992301003
Classification
Brand
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Last Updated
12/23/2022
Active Ingredients
TACROLIMUSApproval Type
New Drug (NDA)
FDA Application
NDA206406On Market Since
9/1/2015
Pharmacological Classes
Price Statistics
The NADAC for ENVARSUS XR 1 MG TABLET has been published 78 times since Oct 20, 2021, and over the history we have for it it has risen 10.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.1904 per EA |
|---|---|
| All-time high | $6.1904 (Apr 12, 2023) |
| All-time low | $5.5833 (Oct 20, 2021) |
| Median price | $5.9810 |
| Average price | $5.9055 |
| Largest weekly change | +3.5% (Dec 28, 2022) |
| Weeks tracked | 78 |
| Tracking since | Oct 20, 2021 |
Generic Alternatives
The matcher finds 14 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 97% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ENVARSUS XR 1 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ENVARSUS XR 1 MG TABLET, manufactured by Veloxis Pharmaceuticals, Inc, is $6.1904 per EA (NDC 68992301003), effective Apr 12, 2023.
How has the price of ENVARSUS XR 1 MG TABLET changed over time?
Over the history we have for it, the NADAC for ENVARSUS XR 1 MG TABLET has risen 10.9%. It has been tracked across 78 weekly CMS publications since Oct 20, 2021.
What are the highest and lowest recorded NADAC prices for ENVARSUS XR 1 MG TABLET?
Since Oct 20, 2021, the NADAC for ENVARSUS XR 1 MG TABLET has ranged from a low of $5.5833 (Oct 20, 2021) to a high of $6.1904 (Apr 12, 2023), with a median of $5.9810 per EA.
Are there cheaper alternatives to ENVARSUS XR 1 MG TABLET?
Yes. 14 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, TACROLIMUS 1 MG CAPSULE (IMMEDIATE RELEASE), is $0.1561 per EA — about 97% below ENVARSUS XR 1 MG TABLET.
Who manufactures ENVARSUS XR 1 MG TABLET?
ENVARSUS XR 1 MG TABLET (NDC 68992301003) is labeled by Veloxis Pharmaceuticals, Inc, and CMS classifies it as a brand product.
Related Drugs
Same classification